NICE Update Alert: New guidance on skin lesion management expected Q2 2026. Check NICE website for latest recommendations.

Minor Surgery in General Practice

From lipomas to toenails: your practical guide to safe, confident minor procedures (Because “minor” doesn’t mean “simple” when it’s your first time)

☕ Tea-Friendly Learning ⏰ For GP Trainees Short on Time 🚩 Red Flag Focused

Date Updated: March 2026

Executive Summary

Minor surgery in UK general practice encompasses a range of procedures from simple excisions to joint injections. This guide covers patient assessment, common procedures, red flags, and practical tips for safe practice.

5+
Common Procedures

Excisions, wound closure, joint injections, toenail surgery, and more

BNF Verified
Drug Doses

All local anaesthetic and medication doses checked against BNF/PCDS

4 Categories
Red Flags

Skin cancer, infection, vascular, and nerve injury warning signs

5 Types
Wound Dressings

Hydrocolloid, foam, alginate, hydrogel, and antimicrobial options

Downloads & Resources

Web Resources
  • PCDS — Skin Surgery & Cryosurgery Hub The UK primary care dermatology society's dedicated surgery section. Technique guides, instructional videos, and downloadable consent forms for excision, curettage, cryotherapy, and LA use.
  • PCDS — Skin Surgery Guidelines (PDF) Comprehensive GP-written PDF covering LA technique, excision, wound closure, lipomas, and cysts. The most referenced free text on UK GP minor surgery courses.
  • PCDS — Cryotherapy Practical Guide Step-by-step liquid nitrogen guide: freeze times by lesion type, timed-spot technique, consent form template, and post-treatment advice leaflet.
  • PCDS — National Treatment & Referral Guide Concise UK referral and management pathways for common skin conditions including BCC, SCC, and actinic keratoses, with GPwER commissioning context.
  • DermNet — Skin Surgery Free internationally respected reference covering excision, curettage, shave biopsy, and punch biopsy with detailed technique descriptions and clinical images.
  • DermNet — Common Skin Lesions (Free CME) Self-directed free CME module covering lesion recognition, histology, and surgical decision-making. Useful for learning to distinguish benign from suspicious lesions before excision.
  • UKHSA TARGET — Antimicrobial Guidance for Primary Care Free prescribing resources covering wound infection, bite wounds, and cellulitis management. Essential for post-procedure antibiotic decisions aligned with UK stewardship.
  • Patient.info Professional Free UK-based clinical articles on minor surgery topics including skin lesion management and referral criteria. Written for primary care clinicians and regularly updated.
  • International Dermoscopy Society — Free Atlas Free dermoscopy reference and lesion atlas. Increasingly important for GPs making excise-vs-refer decisions — helps identify worrying features before committing to a procedure.
  • Wounds UK Free peer-reviewed wound management resources, best practice statements, and dressing selection guides. Widely used in UK community nursing and primary care wound care.
  • RCGP eLearning Platform Hosts the RCGP minor surgery modules and free antimicrobial prescribing summary tables (accessible without membership). Useful for DOPS preparation and CPD.
  • Minor Skin Surgery for Skin Lesions — Commissioning Policy (Vale of York) NHS commissioning and referral policy. Essential for "can I remove this?" decisions — covers what is and isn't routinely funded, when benign lesions qualify, and includes the three-photo advice-and-guidance tip widely adopted across ICBs.
  • GPwER Dermatology & Skin Surgery Framework (BAD/RCGP/PCDS) Competency and accreditation framework for GPs with extended roles. Best resource for capability, governance, and progression — covers expected competencies, training and assessment standards, and maintenance of clinical competence through the 5-year revalidation cycle.
  • Patient.info — Minor Surgery in Primary Care Broad, accessible overview of common primary care procedures written by UK doctors. Lists core minor surgery procedures, useful starting refresher, and includes skin biopsy context alongside contractual and governance requirements.
  • TeachMeSurgery — Elliptical Incision of a Skin Lesion Clear visual surgical skills page covering stepwise ellipse technique, suture closure, and orientation marking. Useful for planning ellipses and revising basic excision technique before supervised practice or DOPS.

Brainy Bites

8 clinical pearls to make you look like a minor surgery wizard

1 Langer's Lines Mnemonic

Think 'Wrinkles': Incisions along natural skin tension lines (Langer's lines) heal with less scarring. On face: horizontal on forehead, around eyes/mouth. On trunk: horizontal. On limbs: longitudinal. If unsure, pinch skin - wrinkles show the lines.

2 3:1 Ellipse Rule

For elliptical excisions, length should be 3x the width. This creates 30° angles at the tips, allowing easy closure without 'dog ears'. Too short = puckering. Too long = unnecessary scar.

3 Lidocaine Dose Calculation

Quick calc: 1% lidocaine = 10mg/ml. Plain max = 3mg/kg (e.g., 70kg patient = 210mg = 21ml). With adrenaline max = 7mg/kg (70kg = 490mg = 49ml). Always aspirate before injecting to avoid intravascular injection.

4 Danger Zones to Avoid

Temporal branch of facial nerve (forehead - causes brow ptosis), Spinal accessory nerve (posterior triangle - causes shoulder drop), Digital nerves (fingers - run along sides), Facial artery (nasolabial fold). Know your anatomy!

5 Cyst Excision Trick

For epidermoid cysts: excise the entire cyst wall intact. If you rupture it, recurrence rate jumps from 5% to 40%. If inflamed/infected, incise & drain first, then excise 4-6 weeks later when inflammation settled.

6 Joint Injection Timing

Steroid injections take 3-7 days to work (not immediate). Warn patients about post-injection flare (10-20%, settles in 24-48h with ice/paracetamol). Effect lasts 6-12 weeks. Limit to 3-4 per year per joint to avoid cartilage damage.

7 Phenol Toenail Trick

After avulsing nail, DRY the nail bed thoroughly before applying phenol (moisture dilutes it). Apply 80% phenol for exactly 3 minutes to nail matrix. Neutralise with alcohol. Expect discharge for 2-6 weeks (normal, not infection).

8 Dressing Selection Mantra

Match dressing to exudate: Dry wound = hydrogel (adds moisture). Low exudate = hydrocolloid. Moderate = foam. Heavy = alginate. Infected = antimicrobial. Cavity = alginate rope. Simple!

Patient Assessment

Pre-Procedure Checklist

History

  • Indication for procedure (symptoms, cosmetic, diagnostic)
  • Duration and change in lesion/condition
  • Previous treatments attempted
  • Allergies (LA, antibiotics, dressings, latex)
  • Medications (anticoagulants, immunosuppressants, steroids)
  • Medical history (diabetes, bleeding disorders, keloid tendency, PVD)
  • Social history (occupation, hand dominance, smoking)

Examination

  • Lesion characteristics (size, shape, colour, texture, mobility)
  • Anatomical location (danger zones, cosmetically sensitive)
  • Surrounding skin (inflammation, infection, scarring)
  • Lymph nodes (if malignancy suspected)
  • Vascular status (pulses if limb procedure)
  • Nerve function (if near nerve)

Consent

  • Explain procedure in lay terms
  • Discuss risks: bleeding, infection, scarring, recurrence, nerve/vessel injury
  • Discuss benefits and alternatives
  • Document consent (written for excisions, verbal acceptable for minor procedures)
  • Ensure patient has capacity and understands

Anticoagulation Management

Risk stratification approach:

Low-risk procedures (continue anticoagulation):

  • Simple skin lesion excision
  • Skin biopsy
  • Joint injection (with caution)

Higher-risk procedures (consider stopping):

  • Large/deep excisions
  • Vascular areas (scalp, face)
  • Multiple procedures

Always weigh thrombotic risk vs bleeding risk. Discuss with patient and consider specialist advice if uncertain.

Diagnostic Approach

Clinical Assessment Framework

Systematic approach to evaluating skin lesions and surgical conditions

ABCDE for Melanoma Screening

A

Asymmetry

One half unlike the other

B

Border

Irregular, scalloped, or poorly defined

C

Colour

Varied shades of brown, black, red, white, blue

D

Diameter

>6mm (pencil eraser size)

E

Evolving

Changing in size, shape, or colour

7-Point Weighted Checklist (Score ≥3 = refer)

Major features (2 points each):

  • Change in size
  • Irregular shape
  • Irregular colour

Minor features (1 point each):

  • Largest diameter ≥7mm
  • Inflammation
  • Oozing
  • Change in sensation (itch/altered sensation)

Ugly Duckling Sign

A lesion that looks or feels different from the patient's other moles. This simple sign has high sensitivity for melanoma detection. If a lesion stands out as the "ugly duckling" among a patient's moles, consider referral even if other criteria not met.

When to Refer vs Manage in Primary Care

Urgent 2-Week Wait Referral

  • Suspected melanoma (ABCDE positive)
  • 7-point checklist score ≥3
  • Ugly duckling lesion with concern
  • Non-healing lesion >4 weeks
  • Squamous cell carcinoma features

Safe for Primary Care

  • Lipomas (soft, mobile, slow-growing)
  • Epidermoid cysts (punctum present)
  • Skin tags
  • Dermatofibromas (dimple sign)
  • Seborrhoeic keratoses (stuck-on appearance)

Differential Diagnosis

Common benign lesions encountered in primary care minor surgery. Learn to distinguish them clinically.

Clinical Features:

  • Soft, doughy consistency
  • Mobile over underlying structures
  • Subcutaneous location
  • Slow-growing
  • Non-tender unless traumatised

Management:

Excision if symptomatic, cosmetically concerning, or diagnostic uncertainty. Use careful dissection with flat scissors held parallel to skin surface to avoid damage to surrounding structures.

Referral Criteria:

Rapid growth, hard consistency, fixed to deep structures, >5cm diameter. Subfrontalis lipomas (lie under frontalis muscle, less obvious when eyebrow raised) require specialist referral due to risk of temporal nerve damage.

Clinical Features:

  • Central punctum (pathognomonic)
  • Fixed to skin, mobile over deeper structures
  • Cheesy discharge if ruptured
  • May become inflamed/infected
  • Common on face, neck, trunk

Management:

Excise entire cyst wall intact to prevent recurrence (5% vs 40% if ruptured). If inflamed/infected, incise & drain first, then excise 4-6 weeks later. Score skin with scalpel only, then use small flat dissecting scissors at angle almost parallel to skin surface to carefully dissect each layer until sac visible.

Referral Criteria:

Recurrent infection, diagnostic uncertainty, cosmetically sensitive area

Clinical Features:

  • Firm, tethered to skin
  • Dimple sign positive (dimples when pinched)
  • Brown/pink colour
  • Usually <1cm
  • Common on legs

Management:

Usually conservative. Excision if symptomatic or diagnostic doubt

Referral Criteria:

Rapid change, bleeding, ulceration, >1cm diameter

Clinical Features:

  • Central arteriole with radiating capillary legs — resembles a spider
  • Blanches completely with direct pressure on central arteriole (pathognomonic)
  • Common in children (usually resolve spontaneously), pregnant women, and patients with liver disease
  • In adults without known trigger — usually benign; multiple lesions should prompt consideration of chronic liver disease
  • Typically on face, neck, upper chest, hands

Management:

Reassure and observe if isolated and asymptomatic (especially in children — high rate of spontaneous resolution). If treatment desired: electrocautery with a fine needle-point tip inserted into the central arteriole produces rapid destruction with excellent results. Cryotherapy is an alternative. Laser treatment available in secondary care for cosmetically significant or multiple lesions.

Referral Criteria:

Multiple spider naevi in an adult — investigate for underlying chronic liver disease before attributing to cosmetic cause. Refer to dermatology for laser treatment if electrocautery not available or lesion is cosmetically prominent.

Clinical Features:

  • Rapidly growing, bright red or dark red, friable vascular nodule — bleeds profusely with minimal trauma
  • Typically 5–10mm, often pedunculated
  • Common on fingers, lips, gingiva, face
  • Often arises following minor trauma or injury
  • More common in pregnancy (can occur on gingiva)
  • Despite the name, it is neither pyogenic (no pus) nor a true granuloma — it is a lobular capillary haemangioma

GP Management:

Curettage and cautery is effective and quick for most lesions. Note that pressure on the lesion during the procedure can be quite painful — warn patient and ensure adequate local anaesthetic. Chemical cautery (silver nitrate) can also induce involution of smaller lesions. Always send excised/curetted tissue for histology — amelanotic melanoma can mimic pyogenic granuloma. Recurrence rate after curettage is higher than after complete excision (~15–40%); if recurrence, consider full excision.

Referral Criteria:

Recurrent lesion after curettage. Lesion on face or near eye. Any doubt about diagnosis — amelanotic melanoma and other vascular tumours must be excluded. Gingival pyogenic granuloma in pregnancy — usually resolves post-partum; refer to oral surgery if persistent.

Clinical Features:

  • Rapid growth over 6–8 weeks — 1–2cm dome-shaped nodule with smooth, shiny surface
  • Central crater of ulceration or a central keratin plug (sometimes projecting as a horn)
  • Flesh-coloured or reddish
  • Arises from hair follicle — mainly on sun-exposed areas: face, neck, dorsum of hands, forearms
  • More common in older, fair-skinned patients with significant UV exposure
  • Spontaneous partial regression may occur over 4–6 months, but leaves a residual scar; surgical management preferred

Management:

Complete excision is the treatment of choice. Shave biopsy alone is inadequate — it cannot reliably distinguish KA from invasive SCC. Send all specimens for histology. Do not observe and wait for spontaneous resolution — this is now discouraged due to the risk of under-treating an SCC.

Referral:

Refer on 2-week wait pathway (NICE NG12) — keratoacanthoma cannot be clinically or histologically distinguished from squamous cell carcinoma with certainty. Treat as suspected SCC until proven otherwise. There is significant regional variation in histopathological diagnosis of KA vs SCC in the UK.

Clinical Features:

  • Rough, scaly patch on chronically sun-exposed skin (scalp, face, dorsum of hands, forearms)
  • Erythematous base with adherent scale — "sandpaper" texture on palpation
  • Usually multiple lesions in field of sun damage
  • May be hypertrophic (thickened) — raised and keratotic
  • Risk of progression to SCC (~1 in 1000 per year per lesion for individual lesion, but cumulative risk significant with multiple lesions)

GP Management Options:

Cryotherapy (liquid nitrogen or nitrous oxide): First-line for isolated thin lesions. One freeze-thaw cycle of 5–20 seconds. For hypertrophic lesions, two cycles may be needed.

Topical treatments (prescribable in primary care):

  • Diclofenac 3% gel (Solaraze) — applied BD for 60–90 days; well tolerated
  • Fluorouracil 5% cream (Efudix) — applied BD for 3–4 weeks; significant inflammation expected (reassure patient this is the treatment working)
  • Imiquimod 5% cream (Aldara) — 3 times weekly for up to 16 weeks for field treatment

Curettage and cautery: Suitable for isolated hypertrophic lesions — removes thickened scale and cauterises base.

Referral Criteria:

Refer if: lesion is thickened, indurated, or ulcerated (features of SCC); lesion fails to respond to treatment; diagnosis uncertain. Extensive field change — consider referral to dermatology for photodynamic therapy (PDT) or field-directed treatment planning.

Clinical Pearl: The Punctum Test

When examining a subcutaneous lump, look for a central punctum (tiny opening). If present, it's almost certainly an epidermoid cyst. If absent and the lump is soft/mobile, think lipoma. If absent and firm/tethered, consider dermatofibroma or other diagnosis. This simple sign has excellent diagnostic accuracy.

Common Procedures

Excision of Skin Lesions

Elliptical excision is the gold standard for removing benign and suspicious skin lesions. Proper technique ensures complete removal, good cosmetic outcome, and adequate tissue for histology.

AreaConsiderations
Cardiovascular
  • IHD: Pain and anxiety can exacerbate cardiac conditions — consider anxiolysis and ensure adequate LA before any stimulation
  • Pacemakers / ICDs: Bipolar coagulation is safe. Monopolar (e.g. Hyfrecator/electrocautery) should probably be avoided with older pacemakers and all implantable defibrillators — use bipolar or chemical cautery instead
  • Valvular disease: No evidence that antibiotic prophylaxis is needed for minor skin surgery. However, infected wounds should be treated before surgery proceeds
  • Raynaud's disease: Extra care needed with peripheral procedures — avoid prolonged tourniquet use; use plain lidocaine (no adrenaline) at peripheral sites
Medications
  • Warfarin: Ideally INR <3.5 before surgery. Extra attention needed for haemostasis throughout. Check INR pre-operatively for large or complex excisions.
  • Aspirin and clopidogrel: Do not stop. Extra attention needed for haemostasis — anticipate more bleeding
  • NSAIDs: No problems with minor surgery
  • If PMH or FH of bleeding problems — organise pre-op FBC and clotting studies
PregnancySkin surgery is best avoided in pregnancy unless benefits outweigh risks (e.g. suspected skin cancer). Where possible, local anaesthetic should be avoided in the first trimester.
AllergiesAsk about: Elastoplast (adhesive tape allergy), antibiotics (for prophylaxis), latex (gloves and surgical couch covering), antiseptic preparations, local anaesthetic (very uncommon — see LA section).
General examinationPatients with pre-malignant lesions or suspected skin cancer must have a thorough examination of the skin at the same visit. Know your anatomy — assess lesion depth, proximity to nerves/vessels, and mobility before marking.
Patient expectationsAlways ask: Is the surgery necessary? What outcome does the patient expect? Discuss risks vs. benefits. Avoid skin surgery on exposed areas immediately before major social occasions.
Children — Topical Local Anaesthetic

Always use topical anaesthetic cream in children before LA injection. Two main options:

  • EMLA cream — takes at least 90 minutes to work; surrounding skin goes white due to vasoconstriction (normal). Apply under occlusion.
  • Ametop gel (tetracaine 4%) — takes only 30 minutes; does NOT cause vasoconstriction. Preferred when speed matters. Contraindicated in neonates under 1 month.
Ring Blocks (Digital Block)
  • Use 2% plain lidocaine — no adrenaline (digit is end-artery)
  • Do not use more than 4ml in fingers — compression of digital vessels can occur with higher volumes, risking vascular necrosis
  • Always time the tourniquet occlusion period — remove promptly and document duration to avoid vascular necrosis
MRSA Protocol

Patients who have had MRSA in the past but have since had negative swabs must still be managed as if they have MRSA — false negative swabs are not uncommon.

  • Schedule MRSA-positive patients at the end of the operating list
  • Remove unnecessary equipment from the room beforehand
  • Clean the room thoroughly afterwards
Indications
  • Diagnostic uncertainty (rule out malignancy)
  • Symptomatic lesions (bleeding, catching on clothing, painful)
  • Cosmetic concerns
  • Patient preference
Contraindications
  • Suspected melanoma — refer for specialist excision with appropriate margins
  • Active infection at site
  • Bleeding disorder (relative — may need specialist setting)
  • Keloid tendency in cosmetically sensitive area
  • Sterile gloves, drapes, gauze
  • Local anaesthetic (lidocaine 1% or 2%, with/without adrenaline)
  • Scalpel (size 15 blade for most lesions, size 11 for small/precise work)
  • Toothed forceps (Adson's), non-toothed forceps
  • Scissors (sharp and blunt dissecting), needle holder
  • Sutures (absorbable deep layers, non-absorbable skin)
  • Specimen pot with formalin
AgentMax doseDurationNotes
Lidocaine 1% plain3 mg/kg (max 200mg = 20ml)30–60 minStandard choice
Lidocaine 1% + adrenaline 1:200,0007 mg/kg (max 500mg = 50ml)2–6 hoursAvoid on digits, nose tip, ear lobes, penis
Lidocaine 2% plain3 mg/kg (max 200mg = 10ml)30–60 minSmaller volume needed
Bupivacaine 0.25% plain2 mg/kg (max 150mg = 60ml)4–8 hoursLonger duration; post-op analgesia
LA Toxicity Warning

Early: Perioral tingling, metallic taste, tinnitus, dizziness. Severe: Seizures, arrhythmias, cardiovascular collapse. Always aspirate before injecting. Never exceed max dose. Inject slowly.

Direction of Incision — Body Site Rules
  • Limbs, abdomen, forehead: Transverse orientation
  • Glabellar area: Vertical orientation
  • Avoid horizontal or vertical sutures on the central cheeks — follow skin wrinkles (relaxed skin tension lines) in this area
  • Over a contour: Orient at right-angles to the contour to avoid a contour defect
  • When uncertain, follow the lines of skin wrinkles (least skin tension lines)
  • Deviation may be necessary depending on the direction the lesion runs
  1. 1Mark: Draw ellipse with 3:1 length-to-width ratio (may need to increase slightly when working over a contour; a smaller ratio may be acceptable in low-tension areas). Both sides of the incision must be of equal length — deviation from this is likely to result in a dog-ear. Include 2–4mm margin for benign lesions. Orient according to body site rules above.
  2. 2Infiltrate LA: Inject around and under lesion. Wait 5–10 minutes for LA effect. Note: the vasoconstrictor effect of adrenaline takes up to 15 minutes to achieve full effect (unlike the LA effect which occurs in 2–3 minutes) — wait at least 15 minutes if haemostasis is critical (e.g. scalp, face, larger lesions). Aspirate before injecting. Pinch skin proximally as needle punctures to reduce pain. Inject slowly as you withdraw — reduces risk of intravascular injection.
  3. 3Incise: Hold scalpel at 90° to skin. Cut through full dermis in one bold movement to prevent jagged margins. At both apexes: reverse the blade and cut toward the centre to avoid overshooting and causing a fish-tail defect. Ensure scalpel is vertical to the skin at start and finish — avoid bevelling.
  4. 4Tissue dissection: Avoid excessive handling of wound edges — use a skin hook or one edge of forceps to elevate tissue (not crushing forceps on the wound edge). Dissect initially with scalpel blade to reach the correct plane, then use blunt scissors (open from closed position) to dissect under the lesion. For lipomas and epidermoid cysts: score skin only with scalpel; use small flat dissecting scissors held almost parallel to skin surface, carefully dissecting each layer of fibre until the sac becomes visible, then curved scissors to dissect around and under the cyst.
  5. 5Undermine (if needed): Only where high skin tension remains after ellipse removal. Avoid undermining on the lower legs — too much undermining can compromise blood supply. If needed, use round-ended scissors facing upwards, separating fatty tissue by repeatedly opening scissors. Difficult undermining or excessive bleeding suggests you are too high (in the dermis). Correct levels:
    • Face: Mid fat
    • Scalp: Subgaleal layer (under the fat, above the periosteum)
    • Trunk and limbs: Deep fat
    • Hands: Just below the dermis
  6. 6Haemostasis: Pressure is always the first step. Gentle bipolar diathermy or unipolar Hyfrecator for small vessels (take care to avoid skin edges). Larger vessels (>1mm diameter) — clamp and ligate with 3/0 or 4/0 Vicryl as a last resort. Use pressure bandages post-operatively where bleeding is more likely (scalp/face lesions, larger/deeper lesions, lipoma on forehead, patients on warfarin).
  7. 7Close: Deep dermal sutures first (absorbable, e.g., Vicryl 4-0 — Monocryl on back/joints; avoid Vicryl on face as causes more tissue reaction). Skin sutures (non-absorbable, e.g., Prolene 5-0 face / 4-0 body / 3-0 limbs) with everted edges. Steri-strips should be applied at 90° to the wound direction on all wounds where practical, in addition to sutures.
  8. 8Dress: Non-adherent dressing. Keep dry 48 hours. Pressure dressings where haematoma risk is higher.
  9. 9Histology: Formalin pot, clearly labelled with patient details, site, and provisional diagnosis. All excised lesions should be sent for histology without exception.
    • Add adequate clinical history to the pathology request form: duration, site, size, and provisional diagnosis — this helps the pathologist and may affect how the specimen is sectioned
    • Histology is not infallible: punch biopsy may miss early lentigo maligna; histological differentiation between moderate/severely dysplastic melanocytic naevus and melanoma can be difficult — all lesions reported as 'incompletely excised dysplastic naevi' must be re-excised
    • Chase all histology results — do not rely on the patient to follow up
Problem Areas — Anatomical Danger Zones

Face: The SMAS (Superficial Musculo-Aponeurotic System) lies below the fat. Nearly all critical structures lie deep to the SMAS. Extra care for:

  • Superficial branches of the temporal artery (superficial to SMAS, runs in front of ear across temple)
  • Temporal branch of facial nerve (temporal area) — damage causes difficulty elevating the eyebrow
  • Marginal mandibular branch of facial nerve (crossing lower border of mandible)
  • Point just below inferior margin of earlobe where facial nerve exits scalp into subcutaneous tissue
  • Subfrontalis lipomas — lie under frontalis muscle; go very deep; lesion becomes less obvious when eyebrow raised

Neck (elderly): External jugular vein may have little covering platysma — use blunt dissection (open scissors from closed position). If vein is cut: pressure + put patient head-down (prevents air embolus). Accessory nerve at Erb's point lies deep to superficial fascia.

Other danger zones: Axilla (brachial plexus branches near surface); upper outer quadrant thigh (lateral cutaneous nerve); lateral popliteal fossa (common peroneal nerve); outer and lower shin (sural nerve — very superficial, commonly used as nerve graft donor).

Lower legs: Avoid excessive skin tension on pre-tibial surface — breaks down easily post-op. Use skin flaps or graft if too large for easy direct closure.

LocationDeep (absorbable)Skin (non-absorbable)Removal
FaceVicryl 5-0Prolene 6-0 or 5-05–7 days
ScalpVicryl 4-0Prolene 4-0 or 3-07–10 days
TrunkVicryl 4-0Prolene 4-010–14 days
Arms/LegsVicryl 4-0Prolene 4-0 or 3-010–14 days
Hands/FeetVicryl 5-0Prolene 5-0 or 4-010–14 days
Back (high tension)Vicryl 3-0Prolene 3-014 days

GP Script: Post-Excision

What to expect: Mild discomfort 2–3 days (paracetamol). Bruising/swelling 1–2 weeks. Scar fades over 6–12 months.

Seek help if: Increasing pain/redness/swelling after 48h; pus or discharge; fever; wound edges separating; excessive bleeding.

Complications
  • Bleeding: Pressure usually settles it; persistent — cautery or suture ligation
  • Infection (1–5%): Flucloxacillin 500mg QDS for 5–7 days; swab if not improving
  • Wound dehiscence: Early (<7 days) — re-suture; late — heal by secondary intention
  • Hypertrophic scar/keloid: Refer dermatology for steroid injection or silicone gel (Dermatix). Higher risk in: Afro-Caribbean patients, younger age, female sex, lesions on chest above nipple line, upper back, shoulders and upper arms, previous history of keloid. Scars can take up to 18 months to fully mature — scars on the back and scalp tend to widen with time. Warn patients of this at consent. Silicon gel (Dermatix) applied thinly twice daily for a minimum of 2 months once wound healed (10–14 days post-op) may reduce degree of scarring in keloid-prone patients.
  • Nerve injury: Usually temporary neuropraxia; refer if >3 months
  • Dog ears: Small dog-ears can be left and will often settle over 18 months. Larger dog-ears should be dealt with at the time of surgery. Revise at 3–6 months if cosmetically concerning.
  • Over-granulation: Occurs when wound is over-stimulated. Treat with 1% silver nitrate applied twice weekly (avoid if cosmesis important — can stain skin). Alternatives: topical Dermovate (clobetasol propionate) or Adcortyl (triamcinolone acetonide) under occlusion, or curettage and cautery of the granulation tissue.
  • Incomplete excision: More likely for lesions on the nose and inner canthus; morphoeic/infiltrative BCC; multi-focal BCC; tumours with ill-defined borders. Always check histology report for margin status and act on incomplete excision promptly.

Punch Biopsy

A cylindrical cutting tool used to take a core of skin tissue. Mainly used for diagnostic purposes but occasionally as definitive treatment for very small lesions. Sizes range from 3–8mm diameter.

Indications
  • Diagnostic biopsy of inflammatory skin conditions (lichen planus, psoriasis, vasculitis, etc.)
  • Diagnostic biopsy of small suspicious lesions
  • Definitive treatment of very small benign lesions
Pigmented Lesions

A punch biopsy on a pigmented lesion must only be used if the lesion can be safely removed to include 2mm of normal surrounding skin. If this cannot be achieved, an elliptical excision should be performed instead. Never punch-biopsy a suspected melanoma — refer for excisional biopsy.

  1. 1Select size: 3–8mm punch. Choose the size that will include the target lesion plus a small margin.
  2. 2LA: Infiltrate lidocaine 1% under lesion. Wait for full effect.
  3. 3Stretch the skin perpendicular to the natural skin tension lines — this produces an elliptical wound (rather than circular) which is easier to close and heals with a less conspicuous scar.
  4. 4Apply punch: Press firmly and rotate with consistent pressure through the dermis until the punch drops into the subcutaneous fat.
  5. 5Remove specimen: Handle very gently using a skin hook or fine needle — do NOT hold with forceps as crushing artefact makes accurate histology difficult.
  6. 6Close: Small punches (3–4mm) may not need suturing. Larger punches and those on well-vascularised areas (e.g. face) will need suturing — 1 or 2 interrupted sutures.
  7. 7Histology: Place in formalin. Include site, size, clinical details, and provisional diagnosis on request form.

Incisional Biopsy

A partial biopsy technique used when a larger tissue sample is needed than a punch biopsy can provide, but where full excision is not yet appropriate or possible. Scenarios for this are uncommon — consider whether full excision (with histology) or referral is more appropriate.

Indications
  • Lesion too large for excisional biopsy or punch biopsy, but tissue diagnosis needed before definitive management
  • Suspected soft-tissue tumour (e.g. sarcoma) where tissue architecture is needed
  • Inflammatory conditions where punch biopsy has been inconclusive
Pigmented Lesions

Incisional biopsy should be avoided in pigmented lesions. If melanoma is suspected, refer for complete excisional biopsy with appropriate margins — partial biopsy of a melanoma risks sampling error and may make staging inaccurate.

Technique Key Points
  • Include some normal surrounding skin at the edge of the lesion to help histological analysis (provides normal reference tissue)
  • State on the pathology form that this is an incisional biopsy — otherwise the specimen may be sectioned the wrong way and the lesion missed
  • New elliptical punch biopsy tools can provide elliptical incisional samples — a useful intermediate option
  • Suturing is usually required afterwards
  • Histology of 'difficult rashes' may not be of additional diagnostic value — consider referral to dermatology rather than in-house biopsy

Shave Excision

Shave excision removes a proud/elevated skin lesion by cutting horizontally across its base. The main use is for benign lesions that protrude above the skin surface. The operator must be confident the lesion is benign before using this technique — if in doubt, perform a full excision with 2mm margins.

Indications
  • Benign proud skin lesions: seborrhoeic keratoses (thick), skin tags, viral warts (as adjunct), dermatofibromata
  • Benign naevi with a significant exophytic/raised component
Always Send for Histology

All shave excision specimens must be sent for histology — even when the diagnosis appears clinically certain. Always excise to a 2mm margin if there is any doubt about benignity.

Risks
  • Scarring: Little scarring occurs in 45% on head/neck, 30% on trunk. In the remainder, scars tend to be smaller than the original lesion and often slightly depressed.
  • Keloid: Uncommon, but does occur in keloid-prone areas
  • Pigmented lesions: Approximately 25% of patients with pigmented lesions removed by shave will develop a flat pigmented area at the site
  • Recurrence: Up to 25% of lesions may recur — warn patients, especially for naevi
Technique
  1. 1Raise the lesion: Inject a good (but safe) amount of LA under the lesion to raise it up and make excision easier. Pinching the lesion between thumb and finger is of additional benefit for smaller lesions.
  2. 2Blade selection: Size 10 blade for larger lesions, size 15 for smaller lesions. A DermaBlade (flexible razor blade) is an excellent alternative — reduces depth variability.
  3. 3Shave: Hold the blade horizontally and shave off the lesion in one smooth stroke at the level of the surrounding skin surface.
  4. 4Tidy up: If wound edges are uneven after shaving, a curette may be used to tidy the base.
  5. 5Haemostasis: Aluminium chloride, electrocautery, silver nitrate, or pressure as appropriate to the site.
  6. 6Wound care: Apply a small amount of Bactroban or chloramphenicol ointment to the wound. Ask patient to apply Vaseline BD for a few days to keep wound moist and aid healing.
  7. 7Histology: Always send specimen in formalin.

Curettage & Cautery

Curettage involves scraping away superficial skin lesions with a curette. Often combined with cautery (heat/chemical) for haemostasis and to destroy residual tissue. Both are claimable under the NHS Minor Surgery Directed Enhanced Service. Suitable for benign superficial lesions only — never use when diagnosis is uncertain, as no histology is obtained from cautery alone.

Three types of cautery are relevant to UK general practice: cryocautery, electrocautery, and chemical cautery (silver nitrate). Operating-theatre-type specialist equipment is outside normal GP scope.

Indications for Curettage
  • Seborrhoeic keratoses (seborrhoeic warts)
  • Viral warts — especially facial warts (curettage preferred over electrocautery for warts)
  • Skin tags (can also use cryotherapy or snip excision)
  • Pyogenic granuloma
  • Molluscum contagiosum
  • Chalazion (meibomian cyst) — if trained in this technique
Curette Types

The curette derives its name from the Latin curare (to care for). Bronze curettes have been used in surgery for thousands of years.

  • Disposable curettes — very sharp, excellent to use; approximately £2–3 each. Ring sizes available: 4mm (facial/precision work) and 7mm (body lesions)
  • Reusable curettes — can be sharpened and re-sterilised; cost-effective for high-volume practice
  • Disposable curettes are preferred for infection control
Keratoacanthoma — Refer. Do Not Curette Without Excluding SCC First.

Current guidance (including patient.info/PCDS and NICE-referenced sources) states that keratoacanthoma is clinically indistinguishable from squamous cell carcinoma and should be referred on a 2-week wait pathway — not curetted in primary care without prior excisional biopsy to exclude SCC.

Curettage has historically been reported to achieve ~90% cure for carefully selected KA, but this does not negate the diagnostic imperative:

  • Shave or curettage biopsy alone cannot reliably exclude invasive SCC — excisional biopsy with adequate margins (4–5mm) is the definitive diagnostic and therapeutic approach
  • Refer on the 2-week wait pathway (NICE NG12 — suspected SCC) — reassure the patient that KA rarely causes serious harm, but a specialist must exclude SCC first
  • Only consider curettage in primary care if clinical diagnosis is absolutely certain, lesion <2cm, not cosmetically sensitive, not on face/head, patient elderly or unfit for excision, and patient counselled that no histological confirmation will result
  • If any doubt — excise and send for histology, or refer
BCC — Not Suitable for Routine GP Curettage

Curettage and cautery has historically been reported as achieving ~90% cure rates for selected BCCs. However, this is not standard primary care practice in the UK. Suspected BCC should be referred. Low-risk BCCs below the clavicle may be excised (not curetted) by GPs with appropriate extended-role competency (GPwER accreditation). When in doubt — refer.

  1. 1Infiltrate LA: Inject lidocaine 1% around and beneath lesion. Wait 5 minutes for full effect.
  2. 2Curette: Hold curette like a pen. Stretch skin taut with non-dominant hand. Scrape lesion with firm pressure in multiple directions until reach normal skin — normal dermis feels gritty and resistant compared to the softer tumour tissue. Do not go beyond the dermis (deeper curettage increases scarring and healing time).
  3. 3Haemostasis / Cautery: Apply electrocautery, cryocautery, or chemical cautery (silver nitrate stick, surface only) to base for haemostasis and to destroy any residual tissue.
  4. 4Dress: Apply non-adherent dressing (e.g. Jelonet). Advise wound may ooze for a few days.
No Histology from Cautery Alone

Curettage destroys tissue architecture. Curettings may be sent for cytology but this is non-diagnostic for malignancy. You cannot exclude malignancy from curettage alone. Only use curettage and cautery when you are clinically certain of the diagnosis. Medical records must be meticulous — document the diagnosis, lesion description, and reason for proceeding without excision. If any doubt: excise and send for histology, or refer.

Post-Procedure Care
  • Keep area clean and dry for 48 hours
  • Expect oozing and crusting for 1–2 weeks — healing by secondary intention (no sutures)
  • Scar usually flat and pale; often better cosmetic outcome than excision for small superficial lesions
  • Hypopigmentation common — warn patient, especially those with darker skin tones

Works by causing cellular lysis after a freeze-thaw cycle. Four techniques are available in primary care:

MethodTemperatureGP practicalityNotes
Liquid nitrogen (LN₂)−196°CModerately convenient — needs planningMost destructive. One application usually sufficient. Applied with cotton-wool buds or proprietary spray gun. Can be kept in Dewar flask for ~48 hours. Supply via local hospital or industrial source — arrange dedicated sessions.
Nitrous oxide (N₂O)−89°CMost convenient — from cylinder, prescribable on FP10Less destructive — may need 2–3 treatments 10–14 days apart. More painful than LN₂. Less skill required.
Commercial mixtures (e.g. Histofreeze)−57°CConvenient, ready to useLeast powerful. Suitable for superficial warts and seborrhoeic keratoses. Less reliable for thicker lesions.
Carbon dioxide snow−78°CNow rarely used in GPLargely superseded by LN₂ and N₂O.
Freeze Times by Lesion
LesionFreeze timeTechnique notes
Viral warts15–30 seconds; double 30s for persistent/mosaic plantar wartsPatient pares flat weekly; repeat every 2–3 weeks. Salicylic acid nightly may hasten resolution. Treat 2mm margin of normal skin.
Seborrhoeic keratoses10–20 seconds (depending on thickness)Larger lesions may benefit from paring down before freezing.
Molluscum contagiosum5–10 seconds onlyShort time; avoid over-treating in children.
Actinic (solar) keratoses10–15 secondsTreat 2mm margin of normal surrounding skin.
Bowen's disease20–30 secondsSpray technique preferred. Include 2mm margin. Do not use Histofreeze/cotton bud for Bowen's.
Small benign molesVariable — only if diagnosis certainIf any doubt, excise for histology instead.
Skin tags5–10 seconds or snip excision preferred 
Danger Areas for Cryotherapy
  • Extensor tendons (MCP/DIP joints): Tendon damage and rupture can occur (rarely) — highest risk at dorsal aspects of MCP and DIP joints. Consider alternative modality.
  • Nail margins: Can cause permanent nail dystrophy — warn and document.
  • Lower legs (gaiter area): Avoid where circulation is compromised — risk of leg ulceration.
  • Freeze times are measured from when the area turns white, not from when cryotherapy begins. Always treat a 2mm margin of normal surrounding skin.
Patient Warnings After Cryotherapy (always document)
  • Throbbing / aching for up to 12 hours — paracetamol usually sufficient
  • Blister formation is normal and expected — advise not to burst; allow to dry off as a natural dressing
  • Dead skin will slough off 7–14 days after treatment leaving a red area
  • Red area fades to normal colour over 6–12 weeks (usually ~6 weeks)
  • Hypopigmentation common — warn especially in patients with darker skin tones; usually temporary
  • Avoid over-treatment: excessive freeze times cause scarring, not better clearance
  • Works by burning tissue via direct current. Cheap machines readily available. Quick to use.
  • Requires local anaesthesia (lidocaine 1% infiltrated around lesion)
  • Excellent haemostasis. Very easy to cause marked scarring — be conservative with application time.
  • NOT suitable for viral warts — highest recurrence rate of any wart therapy; also releases viral particles in smoke (HPV aerosol risk)
  • Needle-point tips available for treatment of spider naevi and capillary flares — insert needle tip into centre of spider naevus and apply brief current
  • Useful as an adjuvant to straight scalpel surgery for stopping bleeding from raw areas, particularly after shave excision
  • Do NOT use electrocautery in wound depths — causes considerable deep tissue damage; surface use only
Fire Risk
  • Avoid spirit-based skin prep immediately before electrocautery — use aqueous chlorhexidine instead; if alcohol used, wait ≥2 minutes for full drying
  • Do not allow cautery tip to contact dressings or drapes

Silver nitrate sticks chemically destroy superficial tissue. Available as pencils (also sold OTC for shaving cuts) and sticks (long match with black silver nitrate head — preferred for clinical use; very inexpensive).

Storage & Handling
  • Store in a dry, dark place (moisture and light degrade silver nitrate)
  • Always wear gloves — silver nitrate permanently stains skin, clothing, and worktops black
  • Warn patients about staining: the discoloration fades as the top layer of skin is shed (1–3 weeks)
Application Technique
  1. 1Dip stick tip briefly in water (galipot) to activate — knock off excess before use
  2. 2Apply petroleum jelly (Vaseline) to protect surrounding normal skin before application
  3. 3Apply with a gentle rolling movement against the lesion until a grey-white colour develops (typically 3–10 seconds)
  4. 4Ensure silver nitrate does not touch surrounding normal skin
Clinical Uses
  • Nasal cautery for recurrent epistaxis (Little's area) — see Nasal Cautery section below
  • Granulation tissue in post-operative wounds — touch lightly to induce involution
  • Pyogenic granuloma — effective; note pressure on lesion can be quite painful, warn patient
  • Small warts — adjunctive use
  • Adjuvant haemostasis after shave excision — surface use only; must not be applied into wound depths (causes deep tissue damage)

Nasal Cautery for Recurrent Epistaxis

Chemical cautery of Little's area (Kiesselbach's plexus on the anterior nasal septum) for recurrent idiopathic nosebleeds is a quick, simple procedure well within the remit of GP minor surgery — provided the practitioner has had supervised prior experience.

Indications
  • Recurrent anterior epistaxis from an identifiable vessel on Little's area
  • No active bleeding at time of procedure (cautery is prophylactic — treat after bleeding has stopped)
  • Visible prominent vessel or recent bleeding point identified on anterior nasal septum
  • Failed conservative measures (saline spray, petroleum jelly moisturisation, Naseptin cream)
Key Contraindications and Safety Rules
  • Do not cauterise both sides of the septum at the same visit — risk of septal perforation
  • Do not perform during active bleeding — control bleeding first
  • Not suitable for posterior epistaxis — refer to ENT
  • Requires a clearly visible bleeding point on the anterior septum — do not cauterise blindly
  • Only perform if you have had supervised prior experience of this technique
  1. 1Ask patient to blow nose to clear clots and allow clear visualisation of the bleeding point.
  2. 2Apply topical LA + vasoconstrictor: Spray lidocaine with phenylephrine (or similar) into the affected nostril. Wait 3–4 minutes for effect — provides both anaesthetic and haemostatic benefit.
  3. 3Protect upper lip: Apply a generous layer of petroleum jelly (Vaseline) to the upper lip and nasal sill to prevent chemical burns from silver nitrate drips. Advise patient to leave this on overnight. This step is medico-legally important.
  4. 4Visualise the bleeding point: Use a nasal speculum with a good light source (headlight or Thudichum speculum under direct light). The area must be free of large clots and debris. Washing the area with 1:10,000 adrenaline solution (from a syringe without needle) can clear debris and temporarily reduce bleeding to improve visualisation.
  5. 5Apply silver nitrate: Dip tip of silver nitrate stick briefly in water (galipot). Apply to the identified vessel using a gentle rolling movement for 3–10 seconds until a grey-white colour develops. You are cauterising a specific vessel — not burning the entire septum.
  6. 6Post-procedure: Advise patient to leave the Vaseline on overnight. Apply Naseptin cream (0.5% neomycin + 0.1% chlorhexidine) BD for 4 weeks, or petroleum jelly if neomycin allergy, to promote healing and prevent crusting. The procedure may need to be repeated.
75% vs 95% Silver Nitrate

Evidence (referenced in NICE CKS Epistaxis 2024) suggests 75% silver nitrate is more effective than 95% at two weeks following application. Use 75% sticks where available. Standard silver nitrate sticks sold for clinical use are typically 75% silver nitrate.

Alternative First-Line: Naseptin Cream

0.5% neomycin + 0.1% chlorhexidine cream (Naseptin), applied to the anterior septum BD for 4 weeks, has been shown to be as effective as silver nitrate cautery for anterior epistaxis. It is an appropriate first-line alternative — consider before cautery, especially in those who cannot attend for a procedure. Contraindicated in peanut/soya allergy (contains arachis oil). Alternative: petroleum jelly (Vaseline) applied BD.

  • Posterior epistaxis (profuse bleeding from deep nasal cavity, especially in older patients)
  • Active bleeding not controlled with first aid or packing in primary care
  • Recurrence despite adequate nasal cautery (2+ courses)
  • Suspected underlying cause (coagulopathy, hereditary haemorrhagic telangiectasia, nasal tumour)
  • Patients on anticoagulation with recurrent significant epistaxis
  • Nasal polyps, suspicion of HHT, unexplained unilateral symptoms

Wound Closure Techniques

Primary closure of traumatic wounds in primary care. Assess carefully — some wounds are better left to heal by secondary intention or require specialist referral.

✅ Suitable for Primary Closure
  • Clean wound <6 hours old (face <24h)
  • Minimal tissue loss
  • No signs of infection
  • Edges can be approximated without tension
  • No foreign body
  • Adequate blood supply
❌ Unsuitable — Refer or Secondary Intention
  • Heavily contaminated/infected
  • Significant tissue loss
  • Bite wounds (except face — discuss specialist)
  • Wounds >12 hours old (>24h face)
  • Underlying structure damage (tendon, nerve, bone)
  • Compromised blood supply
  1. 1Analgesia: Infiltrate LA (lidocaine 1% with adrenaline if not contraindicated)
  2. 2Irrigate: Copious normal saline (at least 200ml). High-pressure irrigation (syringe + 19G needle) removes debris effectively.
  3. 3Debride: Remove devitalised tissue and foreign material. Trim ragged edges minimally.
  4. 4Explore: Check for foreign bodies, depth, tendon/nerve injury.
  5. 5Haemostasis: Achieve before closure (pressure, cautery, or ligature).
Wound Closure Method Comparison
FeatureTissue Adhesive (Histoacryl)Skin-Strip (Steri-strip)Suture
LA requiredNoNoUsually yes
Assistant neededSometimesSometimesRecommended
Key technique stepDry thoroughly; hold edges; apply; hold 30 secDry; apply tincture of benzoin; hold edges; apply stripsLA; choose suture material; close in layers; dress
Wound washingAvoid for 5 daysKeep clean and dryKeep clean and dry
RemovalSelf-sloughs 5–10 days (do not pick)Patient removes when they fall awayGP/nurse removes (timing depends on site)
Best forSmall, superficial, clean wounds; children; facial lacerationsSuperficial, low-tension wounds; childrenDeeper wounds; high-tension areas; excisions
Not suitable forHands, joints, hairy skin, wet wounds, high tensionHairy areas, high tension, wounds >2cmInfected/heavily contaminated wounds

Adapted from Cochrane evidence-based flow diagram comparing minor wound closure techniques.

Simple Interrupted Sutures — best for most wounds
  • Enter skin 3–5mm from edge at 90°. Pass through dermis, exit equal distance opposite.
  • Tie with instrument tie (3 throws synthetic, 4 for silk). Evert edges slightly.
  • Space sutures 5–10mm apart.
Continuous (Running) Suture — long linear wounds

Faster, more haemostatic. Risk: if one break, entire closure fails. Harder to adjust tension.

Mattress Sutures

Vertical: Excellent eversion; good for thick skin (back, palms, soles).

Horizontal: Fragile skin (elderly); distributes tension.

Steri-Strips (Adhesive Skin Closures) — superficial low-tension wounds, children

Technique:

  1. Dry skin thoroughly — moisture prevents adhesion
  2. Apply tincture of benzoin (or similar skin adhesive primer) to the skin on either side of the wound — this significantly improves Steri-Strip adhesion and reduces early peeling. Allow to become tacky (30–60 seconds) before applying strips.
  3. Hold wound edges together
  4. Apply Steri-Strips perpendicular to wound, spaced 2–3mm apart
  5. Apply dressing if necessary

Patient advice: Keep clean and dry. Patient can remove Steri-Strips themselves once wound has healed (usually 5–10 days). Return if any problems.

Not for: Hairy areas, high-tension areas, or wounds >2cm.

Tissue Adhesive (Dermabond, Histoacryl) — small low-tension wounds

Technique (qualified staff):

  1. Dry wound thoroughly
  2. Hold wound edges together
  3. Apply a thin layer of Histoacryl/Dermabond over the approximated edges (not into the wound cavity)
  4. Hold for 30 seconds. Apply 2–3 layers. Allow each layer to dry before applying next.

Post-procedure wound assessment and patient advice:

  • Avoid washing the wound for 5 days — water weakens the adhesive bond
  • A light dressing is optional — the adhesive itself acts as a protective film
  • Do not pick the scab — allow the adhesive to slough off naturally over 5–10 days
  • Return if troubled or if wound opens

Not for: Hands, over joints, high-tension areas, or infected wounds.

Vaccination HistoryClean WoundTetanus-Prone Wound*
Fully immunised, last dose <10 years agoNo vaccineNo vaccine
Fully immunised, last dose >10 years agoNo vaccineBooster dose
Incomplete or uncertain historyComplete courseVaccine + immunoglobulin

*Tetanus-prone: puncture wounds, soil/manure, devitalised tissue, compound fractures, delayed (>6h) surgical intervention.

Not routinely required for clean wounds. Consider for:

  • Bite wounds (human or animal) — Co-amoxiclav 500/125mg TDS for 3 days prophylaxis or 5 days treatment
  • Heavily contaminated wounds
  • Immunocompromised patients
  • Diabetic foot wounds
  • Wounds with delayed presentation

GP Script: Wound Care

First 48h: Keep dry and covered. Elevate if possible. Paracetamol for pain (avoid NSAIDs first 48h).

After 48h: Can shower — pat dry gently. Change dressing if wet/soiled.

Suture removal: Face 5–7 days | Scalp 7–10 days | Trunk/arms/legs 10–14 days

Intra-Articular & Peri-Articular Injections

Corticosteroid injections and synovial aspiration are fundamental skills in musculoskeletal medicine. They are used for both diagnosis and treatment of joint, bursal and soft-tissue problems in primary care.

Indications for Joint Aspiration (Diagnostic)
  • Mandatory if septic arthritis suspected
  • Strongly advised if crystal arthropathy (gout/pseudogout) or haemarthrosis suspected
  • Differentiation of inflammatory from non-inflammatory arthritis
  • Tense or painful effusion (therapeutic decompression)
  • Prior to steroid injection in an acutely inflamed joint (always aspirate first to exclude sepsis)
Indications for Joint Injection (Therapeutic)
  • Inflammatory arthritis (RA, psoriatic, crystal arthropathy)
  • Osteoarthritis (symptomatic relief)
  • Bursitis (subacromial, trochanteric, olecranon, prepatellar, anserine)
  • Tendinitis (De Quervain's, trigger finger, carpal tunnel, plantar fasciitis)
Synovial Fluid Findings
FindingNormalOsteoarthritisRA / InflammatorySeptic Arthritis
Gross appearanceClearClearOpaqueOpaque
Volume (ml) knee0–11–105–505–50
ViscosityHighHighLowLow
WCC /mm³<200200–10,0005,000–75,000>50,000
% Polymorphs<25%<50%>50%>75%

Send all diagnostic aspirates for: total and differential WCC, culture and sensitivity (gram stain, MC&S), polarised light microscopy (urate/pyrophosphate crystals). Never rely on one test alone — crystal arthritis and infection can coexist.

Absolute Contraindications to Injection
  • Infection at site or systemic infection (bacteraemia)
  • Suspected septic arthritis — aspirate for diagnosis, do NOT inject steroid
  • Adjacent osteomyelitis
  • Haemarthrosis (bloody joint aspirate — investigate before injecting)
  • Periarticular cellulitis, severe dermatitis or soft-tissue infection overlying the site
  • Joint prosthesis — refer to orthopaedics
  • Fracture through the joint; osteochondral fracture
  • Impending joint replacement surgery (scheduled within days)
  • Uncontrolled bleeding disorder or coagulopathy
  • Poorly controlled diabetes mellitus (relative — weigh carefully; always warn about glucose monitoring)
Inject with Caution (Relative Contraindications)
  • Bleeding disorder or anticoagulation — weigh risk vs benefit carefully
  • Previous injection <3 months ago (limit 3–4 per year per joint)
  • Lack of response to previous injections — suggests wrong site or wrong diagnosis
  • Tendon at high rupture risk (Achilles, patellar) — avoid direct tendon injection
  • Charcot joint / neuropathic joint — injection may worsen joint destruction
  • Neurogenic disease or tumour affecting the joint — exclude before injecting
  • Active infections elsewhere (e.g. TB) or immunosuppressed patients — infection risk is elevated
  • Hypothyroidism — associated with periarticular problems; ensure treated before injection
ItemDetails
Skin preparationAntiseptic solution (povidone-iodine or chlorhexidine), alcohol swabs, 4×4 gauze pads
Local anaesthetic1% lidocaine (mixed with corticosteroid in same syringe or injected separately)
Needles — large joints21G (green) for knee, shoulder, ankle
Needles — medium joints21–23G for elbow, wrist, trochanteric bursa
Needles — small joints23–25G for fingers, toes, MCP, PIP joints
Needles — aspiration18G for purulent effusions; 21G for routine knee aspiration
Syringes3–5ml for injection + anaesthetic; 10–50ml for therapeutic aspiration
MiscellaneousSterile gloves, forceps (to change syringe without touching needle), specimen containers
Needle Length

Standard needle lengths work in most patients. Use longer needles (or spinal needles) for large/obese patients. Purulent effusions require 18G or 16G to drain fully. Failure to drain a septic joint fully should prompt urgent referral for washout.

Note: Doses given for methylprednisolone acetate (Depo-Medrone 40mg/ml) as primary reference. For triamcinolone acetonide (Kenalog 40mg/ml), use the lower figure of the range. For periarticular lesions, use methylprednisolone acetate (less skin atrophy risk than triamcinolone).

Corticosteroid Potency — Increasing Order

Hydrocortisone acetate (weakest, shortest-acting) → Methylprednisolone acetate (Depo-Medrone, intermediate) → Triamcinolone acetonide (Kenalog, most potent, longest-acting)

Use the weakest agent adequate for the indication. For superficial periarticular lesions (tennis elbow, De Quervain's), use hydrocortisone acetate — triamcinolone carries a higher risk of skin atrophy and hypopigmentation at superficial sites. Reserve triamcinolone for larger, deeper joints (knee, shoulder) where longer duration is needed.

Site / JointDepo-Medrone (methylprednisolone)NeedleGP scope
Knee (large)20–80mg21G✓ Routine GP
Shoulder / glenohumeral40–60mg21G✓ Routine GP
Subacromial bursa30–40mg21–23G✓ Routine GP
Elbow (medium)20–40mg21–23G✓ Routine GP
Tennis elbow (periarticular)10–25mg hydrocortisone acetate (NOT Depo-Medrone — skin atrophy risk)23G✓ Use cautiously (see note)
Olecranon bursa20mg22G✓ Routine GP
Acromioclavicular joint10–20mg23G butterfly or 22G✓ Routine GP
Wrist joint20–40mg23G✓ Routine GP
Carpal tunnel20–40mg25G✓ Routine GP
De Quervain's (periarticular)20–30mg25G✓ Routine GP
Trigger finger (tendon sheath)10–20mg25G or 23G butterfly✓ Routine GP
First CMC joint (thumb base)15–30mg23–25G✓ Routine GP
Finger / MCP / PIP joints10–15mg25–27G✓ Routine GP
Ankle (medium)20–40mg22–23G✓ Routine GP
Subtalar joint20–30mg22G✓ Experienced GP
Plantar fascia20–30mg23G✓ Routine GP
Trochanteric enthesopathy30–40mg22G (1.5 inch or spinal for obese)✓ Routine GP
Anserine bursitis20–30mg22G✓ Routine GP
Morton's neuroma20–30mg22G⚠️ Specialist preferred
MTP joints10–20mg22G✓ Routine GP
Trigger points3–5ml 1% lidocaine (NO corticosteroid)22G✓ Routine GP
Hip jointDiagnostic aspiration only — no dose range givenImaging-guided⚠️ Specialist / imaging guidance required

The patient should be positioned supine or in a comfortable recumbent position, as fainting (vasovagal) is a real risk. Explain the procedure fully. Have the patient sign consent.

  1. 1Consent: Explain risks (infection <1 in 15,000, post-injection flare ~5%, skin depigmentation, fat atrophy, tendon rupture, systemic effects); benefits; alternatives.
  2. 2Identify landmarks: Palpate bony landmarks and mark the entry point with a thumbnail imprint or pen mark.
  3. 3Aseptic technique & ensure area is DRY: Chlorhexidine or povidone-iodine skin prep. Sterile gloves. No-touch technique for the needle. Ensure the cleaned area is completely dry before injecting — especially with iodine-based antiseptics; moisture can dilute the antiseptic and increases infection risk.
  4. 4Infiltrate skin (optional): For painful periarticular injections, infiltrate skin and subcutaneous tissue with 1% lidocaine. Many experienced GPs omit this for small joints where a quick single needle thrust is less painful than local anaesthesia.
  5. 5Prepare syringe — 1 or 2 needle technique:
    • 1-needle technique: Draw up lidocaine + corticosteroid into the same syringe and mix well. Inject the mixture in one step. Simple and quick.
    • 2-needle technique: Inject lidocaine first with a small needle. Wait 3–5 minutes. Then use a separate, larger-bore needle to inject the corticosteroid alone. This allows the anaesthesia to be fully effective before the potentially painful steroid injection. Preferred for sensitive sites or anxious patients.
  6. 6Insert needle: Advance until in joint space — a "pop" is felt as needle enters the capsule, and there is loss of resistance. Free flow of fluid confirms intra-articular position.
  7. 7Aspirate first: Before injecting, aspirate — check not in blood vessel; if effusion present, drain fully before injecting steroid. If blood, withdraw and reposition.
  8. 8Inject: Should flow easily with minimal resistance. High resistance = may be in tendon — withdraw slightly and reposition.
  9. 9Withdraw: Withdraw swiftly. Apply light pressure with gauze for a few minutes. Apply simple adhesive plaster.
  10. 10Rest 24–48 hours: Advise patient to rest the injected joint for 24–48 hours to minimise leakage and improve anti-inflammatory response.
Troubleshooting Aspiration

If fluid flow stops, the needle may have clogged with synovial membrane or debris. Rotating the needle, withdrawing slightly, or re-injecting a small amount of fluid will often unclog it. For thick purulent fluid, use 18G or 16G needles.

Finger / MCP / PIP Joints

Indications: RA, psoriatic arthritis, active Bouchard's nodes

Approach: Dorsolateral, digit in semiflexion. Insert 25–27G needle into joint space. Corticosteroid injection produces circumferential distension of the joint.

Precaution: Do not overdistend — fluid tends to back up; maintain firm gauze pressure ≥5 minutes.

Complications: Joint hyperlaxity, capsular calcification (usually inconsequential).

Trigger Finger (Flexor Tendon Sheath)

Indications: Trigger finger; flexor tenosynovitis in RA, psoriatic arthritis.

Approach: Just distal to palmar crease of thumb (proximal crease), or distal palmar crease for index/long/ring/little fingers. Needle at 45° distal inclination. Up to 3 injections, 3 weeks apart.

Precaution: Avoid intratendinous injection. Reciprocal needle movement on gentle finger motion indicates tendon engagement — back up by 1mm, free needle, then inject.

Complications: Superficial fat atrophy; tendon rupture is rare but reported.

De Quervain's Tenosynovitis

Indications: Inflammation of abductor pollicis longus and extensor pollicis brevis at radial styloid (positive Finkelstein's test).

Approach: 25G needle aimed at radial styloid. Needle is pulled back 1mm and injection attempted — successful injection distends the sheath distally to the metacarpal base.

Precaution: Do not inject into grossly thickened sheaths (mycobacterial infection may be present). Keep corticosteroid within the sheath.

Complications: Skin hypopigmentation (common); skin atrophy with ecchymosis in elderly.

Carpal Tunnel Syndrome

Indications: All aetiologies except acute (fracture/haemorrhage) and late-pregnancy CTS.

Approach: Wrist extended 30°. Just distal to distal wrist crease, medial to palmaris longus (absent in 25% — use midline if so). Insert 25G needle 1cm deep at 45° distal and lateral inclination.

Precaution: If paraesthesias occur, the median nerve is engaged — withdraw and reposition. Reciprocal movement on finger motion = tendon engagement; reposition.

Clinical pearl: A properly fitted neutral-position wrist splint minimises intracarpal pressure and complements injection therapy.

First CMC Joint (Thumb Base OA)

Indications: Painful OA — "square hand", grating and tenderness at the prominence.

Approach: In the anatomical snuffbox. Joint entered between abductor pollicis longus anteriorly and extensor pollicis longus posteriorly. Thumb flexed across palm to expose joint.

Precaution: Avoid the radial artery (course varies; may encircle the joint line).

Complications: None if radial artery is avoided.

Wrist Joint

Indications: Acute arthritis (gout, pseudogout most common); RA, sterile synovitis.

Approach: Dorsal, just distal to Lister's tubercle (dorsal distal radius prominence), ulnar to extensor pollicis longus tendon. Wrist slightly palmar-flexed to open the joint.

Precaution: No important neurovascular structures at this entry point.

Ganglia

Indications: Routine dorsal ganglia (highly effective with corticosteroid injection). Ganglia within the carpal tunnel or >3cm should be treated surgically.

Approach: Aspirate ganglia contents first (very viscous, translucent fluid — confirms ganglion). If fluid is different, culture and inspect for crystals.

Precaution: In wrist ganglia, rule out radial artery aneurysm (expansile, pulsatile — distinct from focal pulse of normal adjacent artery).

Elbow Joint (3 Approaches)

Indications: Aspiration in acute arthritis; injection in RA, psoriatic arthritis. Elbow held flexed at 90° for all approaches.

Posterior: Palpate depression in midline between two halves of triceps tendon at back of elbow. Needle perpendicular to skin into olecranon fossa.

Inferolateral: Midpoint cleft between olecranon tip and lateral epicondyle. Insert perpendicularly, aiming at joint centre.

Lateral: Radiocapitular joint — from side, just proximal to radial head. Needle passed tangentially between the two bones.

Precautions: No major neurovascular structures at lateral/posterior approaches.

Olecranon Bursa

Indications: Diagnosis of effusion; treatment of aseptic bursitis refractory to conservative management. Negative bursal fluid culture required before injecting steroid.

Approach: Lateral through normal skin, aiming at centre of bursa.

Precaution: Taps at tip of bursa may create a chronic leak (skin is maximally stretched here). Medial approach may damage the ulnar nerve. In traumatic/idiopathic bursitis, try conservative management first (avoid leaning on elbow for 3 months).

Complications: Skin atrophy, pain on leaning, septic bursitis (risk of 20mg triamcinolone hexacetonide; lower risk with 20mg methylprednisolone acetate).

Tennis Elbow (Lateral Epicondylitis)

⚠️ Current evidence update (NICE CKS 2024): Corticosteroid injection produces good short-term relief (4–6 weeks) but is associated with worse outcomes at 3–12 months compared to physiotherapy or wait-and-see. It is no longer recommended as first-line treatment. Reserve for failed conservative management after ≥6 weeks. Avoid repeated injections — associated with chronic pain and tendon rupture risk.

If injecting: Use short-acting steroid (hydrocortisone acetate) rather than Depo-Medrone — lower risk of skin atrophy. Avoid long-acting preparations. Avoid injecting too superficially (fat necrosis risk).

Approach: At point of maximum tenderness on lateral epicondyle. Pass 23G needle to periosteal contact. Infiltrate with 2–3ml lidocaine. Inject steroid at the tenoperiosteal junction.

Complications: Transient increase in pain in ~40% patients (warn in advance). Repeated infiltrations may result in chronic pain. Avoid subcutaneous injection (fat necrosis, hypopigmentation).

Golfer's Elbow (Medial Epicondylitis)

Pathology: Tendinosis of the common flexor origin at the medial epicondyle (pronator teres and flexor carpi radialis most commonly involved). Overuse injury from repetitive wrist flexion and pronation. Accounts for 10–20% of all epicondylitis diagnoses.

⚠️ Current evidence (2024): Like lateral epicondylitis, corticosteroid injection provides short-term relief (<6–8 weeks) but has no proven long-term benefit and may increase recurrence rates. Use only after failed conservative management (rest, physiotherapy, analgesia, counterforce brace).

⚠️ Beware the ulnar nerve — it runs in the cubital tunnel behind the medial epicondyle. Medial elbow injection carries risk of ulnar nerve damage. Do NOT inject the medial compartment of the elbow joint without clear landmarks. Never inject into the nerve (electric-shock sensation = stop immediately).

Position: Patient supine or seated, arm in comfortable abducted position at side, elbow flexed to 45°, wrist supinated.

Approach: Identify point of maximum tenderness on the medial epicondyle (origin of common flexor tendon). Insert 23G needle perpendicular to skin at this point. Advance to bone contact, then withdraw 1–2mm. Inject corticosteroid slowly (peppering technique — fan the needle in multiple passes around the tenoperiosteal insertion).

Precautions: Avoid injecting too superficially (fat atrophy). Stay lateral to the medial epicondyle tip to avoid the ulnar nerve coursing in the cubital tunnel just posterior and medial to it. If paraesthesias occur in the little or ring finger, withdraw immediately — the ulnar nerve has been encountered.

Complications: Ulnar nerve injury (from misplaced injection), post-injection flare (~40% transient pain increase — warn patients), skin atrophy, tendon rupture risk with repeated injections.

Alternatives: Physiotherapy with eccentric loading exercises is the recommended first-line treatment. PRP injection increasingly used for chronic/refractory cases.

Glenohumeral Joint (Shoulder)

Indications: Aspiration in acute arthritis; injection in RA, spondyloarthropathy, early frozen shoulder, OA. Aspiration before injection in acutely inflamed shoulder.

Posterior approach (preferred): Patient sitting with arm relaxed. Palpate posterior acromion margin. Insert needle 1cm below and 1cm medial to posterolateral corner, aiming anteriorly towards coracoid process until bone touched.

Anterior approach: Patient sitting, arm hanging at side, elbow 90°, forearm in sagittal plane. Enter 1cm distal and 1cm lateral to coracoid process. Some lidocaine injected ahead of needle as it advances.

Precautions: Posterior approach preferred — less apprehension, needle farther from neurovascular structures. Watch for vasovagal in susceptible patients. Dry tap may indicate severe synovitis — repeat under fluoroscopic or US guidance.

Subacromial Bursa

Indications: Subacromial impingement, calcific tendinitis.

Note: Only ~50% of injections reach the bursal sac even with accurate technique — but results can still be excellent even without direct bursal entry.

Posterolateral approach (most common for GP): Patient sitting or lying. Posterior and lateral aspect of shoulder, inferior to lower edge of posterolateral acromion. Insert needle inferior to acromion at the lateral shoulder and direct toward the patient's opposite nipple — this landmark ensures the needle travels under the acromion into the bursal space. Advance to full needle length. Easy flow indicates bursal location.

Anterior approach: Needle anteroposteriorly flush with inferior acromion surface, 1cm lateral to acromioclavicular joint. Once coracoacromial ligament passed, resistance ceases. Easy flow = bursal location.

Precautions: Chair with armrests; have assistant present (vasovagal risk). Do not inject deeply into rotator cuff tendon.

Acromioclavicular (AC) Joint

Indications: Acute arthritis, OA, RA, spondyloarthropathy.

Approach: Needle perpendicular to articular cleft; advance 0.5cm; aspirate or inject to distend joint.

Precautions: AC joint is very narrow with a partial meniscus — procedure is technically demanding. Suspect septic AC arthritis in IV drug users and patients with indwelling subclavian catheters. Do not inject if sepsis suspected.

Bicipital Tendinitis

Indications: Bicipital tenosynovitis. Note: most cases are secondary to subacromial impingement — treat subacromial bursa first; use this injection only if direct tenosynovitis confirmed.

Approach: Palpate bicipital tendon (bicipital groove). Mark on skin. Needle directed superiorly, tangentially to tendon. Inject under low pressure only.

Precautions: Biceps tendon integrity may already be compromised by subacromial impingement. Post-injection rupture risk is real — inject tangentially, not directly into the tendon.

Hip Region
Hip Joint

Indications: Diagnostic aspiration for septic arthritis, differentiating septic arthritis from aseptic loosening in prosthetic hip.

⚠️ Specialist Procedure

Hip joint aspiration is technically demanding and carries significant risk of injuring the femoral neurovascular bundle. Requires imaging guidance (fluoroscopy, US, or CT). This is in the realm of orthopaedics and radiology — refer rather than attempt in primary care.

Trochanteric Enthesopathy ('Bursitis')

Note: This condition is better described as gluteal enthesopathy (stress enthesopathy at gluteus medius/minimus insertion), not true bursitis in most cases.

Indications: Trochanteric pain syndrome refractory to conservative management.

Approach: Patient on opposite side. Palpate greater trochanter along femur distally to proximally. Point of maximal tenderness at posterior corner of greater trochanter. Needle inserted vertically to periosteal contact. Infiltrate lidocaine radially (cone 3cm wide, half on bone, half in proximal soft tissue). If pain relieved, infiltrate corticosteroid in same area.

Precaution: Needle must be long enough to reach bone (spinal needle for obese patients).

Clinical pearl: Address the underlying cause (foot pronation, leg length discrepancy, knee/hip/back disorder) for sustained relief.

Knee Region
Knee Joint

Indications: Effusion in any aetiology; corticosteroid injection in RA, OA, spondyloarthropathy, crystal-induced synovitis.

Medial approach (preferred for injection with large effusion): Supine, knee extended. Medial patellofemoral approach — aim needle to patellar undersurface mid-distance between upper and lower patellar poles. Medial approach preferred as lateral patellofemoral cleft is narrower and the lateral joint capsule is tougher.

Superolateral approach (alternative — especially useful for effusion): Patient on couch, knee slightly bent. Palpate the superior-lateral aspect of the patella. Mark a point 1 fingerbreadth above and lateral to this site. Clean. Inject LA then corticosteroid at this site directed medially and posteriorly under the patella.

Precaution: In RA, beware superimposed septic arthritis — aspirate first if acutely inflamed. Postpone injection until negative synovial fluid culture is available.

Baker's Cyst

Management: Aspiration or injection of the cyst itself is generally unnecessary. Baker's cysts develop in connecting gastrocnemius-semimembranosus bursae and depend on excessive intra-articular fluid from the knee. Treat the underlying knee disorder — systemic treatment, corticosteroid injection into the knee joint, or surgery (arthroscopic meniscectomy/synovectomy) to address the source.

Anserine 'Bursitis'

Indications: Anserine bursitis syndrome — medial knee pain at the pes anserinus (semitendinosus/gracilis/sartorius insertion on anteromedial tibia). Almost always secondary to genu valgum, patellofemoral OA, etc.

Approach: Follow medial border of thigh with knee in semiflexion to where a mark is placed on tibia. Bring knee to extension; insert needle perpendicularly to tibial contact. Infiltrate 3cm area adjacent to periosteum.

Precaution: Paresthesias along medial leg indicate saphenous nerve — reposition needle.

Clinical pearl: Condition will recur unless the primary problem (genu valgum, patellofemoral OA) is addressed. Initiate isometric quadriceps exercises immediately.

Ankle & Foot
Ankle Joint

Approach: Supine, foot in slight plantarflexion. Seek cleft between tibia and talus by gently flexing and extending the foot. Insert needle vertically medial to anterior tibialis tendon.

Precaution: Avoid the dorsalis pedis artery (lateral to approach).

Subtalar Joint

Indications: As for the ankle (inflammatory arthritis, OA).

Approach: By gently inverting and everting the foot, find soft cleft (sinus tarsi) anterior to lateral malleolus. Insert needle perpendicularly towards tip of medial malleolus. Aspiration of fluid proves articular insertion.

Precautions: None specific. Inject under low pressure.

Plantar Fascia

Indications: Refractory plantar fasciitis after failed conservative management (stretching exercises, footwear modification, insoles, physiotherapy ≥3 months). Per NICE CKS, discuss benefits AND risks before offering injection — plantar fat-pad degeneration and fascia rupture are real risks.

Approach: Medial approach from thinner skin — do NOT approach from the direct plantar surface (thicker skin, more painful, fat-pad damage risk). Patient indicates the tender spot. Enter from the medial side of the heel and direct needle posterolaterally toward the calcaneal insertion. Deposit small blebs of corticosteroid as near to the bony insertion as possible.

Safety Precautions
  • Do not inject directly into the body of the fascia — inject near the calcaneal insertion, not through the fascia itself; intratendinous injection significantly increases rupture risk
  • Avoid the fat pad — fat-pad atrophy causes chronic pressure heel pain
  • Repeated injections discouraged — max 1–2; allow 2–3 weeks between reinjections
  • Warn patient: the procedure is painful and long-term benefit is not proven
MTP Joints

Indications: Aspiration for suspected gout (first MTP most common); injection in hallux rigidus, RA, spondyloarthropathies.

Approach: Dorsal, lateral or medial to extensor tendon. Slight passive plantarflexion opens the joint. Attempt aspiration before injection.

Morton's Neuroma

Indications: Morton's neuroma (interdigital neuroma).

Approach: Dorsal between metatarsal heads. Needle advanced plantarly ~2cm, through intermetatarsal ligament (tough fibrous resistance). Inject under low pressure. Up to 2 reinjections 2–3 weeks apart.

⚠️ Specialist Preferred

This procedure should only be performed by those with a thorough knowledge of foot anatomy. Refer to podiatric surgeon or orthopaedics if not experienced.

Trigger Points (Myofascial Syndromes)

Indications: Acute cases where pressure on a point or nodule consistently reproduces the patient's pain.

Approach: 22G needle aimed at the tender point or nodule centre, infiltrated radially throughout the indurated area.

Important: Use local anaesthetic ONLY (3–5ml 1% lidocaine or 0.25% bupivacaine) — do NOT inject corticosteroid at trigger points.

Complications: None. Up to 2 reinjections 2–3 weeks apart are allowed.

GP Script: Post-Injection

Pain after the injection: The local anaesthetic wears off after approximately 2 hours — pain will return at this point and may temporarily be worse than before the injection. This is normal. Warn patients explicitly so they are not alarmed.

What to expect: The steroid takes 3–7 days to produce its anti-inflammatory effect. If pain is severe or increasing after 48 hours, seek advice — this could indicate a post-injection flare or, rarely, infection. Facial flushing occurs in up to 40% — transient, settles in 1–3 days (always warn before injecting).

Post-injection flare (~5%): Apply ice to the area for 15 minutes every hour for the first few hours. Continue NSAIDs — they reduce the risk and severity of post-injection flare. Flare usually resolves within 24–48 hours.

Activity: Rest the joint for 24–48 hours. Effect lasts 6–12 weeks. Max 3–4 per year per joint.

Seek help if: Increasing pain, redness, swelling, warmth after 48h; fever; any pain not settling within 48h.

Complications in Detail
ComplicationDetails & Management
Infection / Septic arthritisRisk ~1 in 15,000 procedures. Hot swollen joint + fever post-injection = urgent orthopaedic referral same day. Requires aspiration, IV antibiotics, possible joint washout. Always use aseptic technique.
Post-injection flareCorticosteroid crystal-induced synovitis in ~5% of intra-articular injections. Pain appears several hours after injection, lasts hours to 1 day. Persisting swelling/pain beyond 48h suggests iatrogenic infection — re-aspirate and culture.
Facial flushingVery common (~40% of cases). Transient and inconsequential; resolves in 1–3 days. Always warn patients before injecting — failure to warn is a common source of complaints.
Skin atrophyFrequent with superficial infiltrations and olecranon bursa injections. Cigarette-paper-like skin, recurrent ecchymosis, chronic pressure pain. More likely in elderly. Caused by corticosteroid escaping into subcutaneous tissue — ensure deep injection and correct site.
Skin hypopigmentationParticularly common with De Quervain's injections. May be disfiguring in darker skin. Usually resolves in a few months to 2 years.
Tendon ruptureRare but serious. Risk minimised by avoiding direct injection into the tendon body (inject around, not into). High risk sites: Achilles, patellar, biceps tendons. Athletes with multiple Achilles infiltrations are at particular risk.
Corticosteroid arthropathyAbuse of intra-articular injections may result in a Charcot's-like arthropathy similar to calcium pyrophosphate deposition disease. Avoid excessive frequency.
OsteonecrosisA reported complication of abused articular or soft tissue corticosteroid infiltrations. Rare with appropriate use.
Corticosteroid-induced osteoporosisPatients serially injected for recurrent tendinitis (e.g. tennis elbow) are at enhanced risk during the injection period, particularly if prolonged bed rest or low calcium intake is also present. Intra-articular route has less systemic effect than oral steroids, but risk is not zero with repeated injections.
Systemic effectsTransient pituitary inhibition for several days. Serial infiltrations may cause adrenal suppression. Hyperglycaemia in diabetic patients (warn to monitor blood glucose for 48h post-injection).

Toenail Avulsion with Phenol Ablation

Partial or total nail avulsion with phenolisation of the nail matrix is the definitive treatment for recurrent ingrowing toenails. Success rate >95% with proper technique.

Indications
  • Recurrent ingrowing toenail (onychocryptosis)
  • Failed conservative management (cotton wool packing, nail cutting technique)
  • Chronic paronychia, involuted/pincer nail
Contraindications
  • Active infection — treat with antibiotics first, then operate 2–4 weeks later
  • Peripheral vascular disease — check pulses; absent = refer to vascular
  • Diabetes with neuropathy/PVD (relative — higher infection risk; refer if severe)
  • Bleeding disorder
  • Sterile gloves, drapes, gauze
  • Lidocaine 1% or 2% plain — NO adrenaline (digit is end-artery)
  • 5ml syringe with 25G needle
  • Tourniquet (Penrose drain or finger tourniquet)
  • Nail elevator (Thwaites or MacDonald)
  • Nail splitter (English anvil pattern)
  • Artery forceps (straight)
  • 80% phenol solution
  • Surgical spirit or isopropyl alcohol (to neutralise phenol)
  • Cotton-tipped applicators
  • Non-adherent dressing (e.g., Jelonet)
  1. 1Digital ring block: Inject 2–4ml lidocaine 1% plain at base of toe, both sides. Wait 5–10 min. Test anaesthesia. DO NOT use adrenaline.
  2. 2Apply tourniquet: Penrose drain at base of toe, secured with artery forceps. Bloodless field.
  3. 3Free nail: Nail elevator under nail plate, sweep side to side, distal to proximal.
  4. 4Split nail (partial): Nail splitter longitudinally (lateral 1/4 to 1/3). Skip for total avulsion.
  5. 5Avulse nail: Artery forceps on nail. Rotate towards centre while pulling distally.
  6. 6DRY THE NAIL BED — CRITICAL: Gauze dry the nail bed and matrix thoroughly. Moisture dilutes phenol and causes failure.
  7. 7Apply phenol: 80% phenol on cotton-tipped applicator to nail matrix (under proximal nail fold) for exactly 3 minutes. Repeat with fresh applicator for full coverage.
  8. 8Neutralise: Surgical spirit or isopropyl alcohol-soaked gauze. This prevents chemical burns.
  9. 9Release tourniquet: Check for bleeding.
  10. 10Dress: Jelonet + gauze. Bandage loosely — not tight (ischaemia risk).

GP Script: Post-Toenail

What to expect: Discharge from the toe for up to 6 weeks is completely normal — this is the phenol reaction, not infection. Keep area clean and covered.

Activity: Elevate foot 24–48h. Open-toed footwear until healed. Nail bed heals fully in 6–12 weeks.

Seek help if: Increasing pain; spreading redness or swelling; fever; nail spicule growing back into skin.

Complications
  • Infection: Flucloxacillin 500mg QDS for 5–7 days; swab if not improving
  • Phenol burn: Inadequate neutralisation; treat with wound care
  • Spicule formation: Residual matrix grows nail shard — requires repeat phenolisation
  • Nail regrowth (~5%): Incomplete phenolisation or failure to dry nail bed first
  • Digital ischaemia: Rare; adrenaline use (contraindicated) or over-tight tourniquet

Wound Dressing Selection

Choose the right dressing for the wound's exudate level, infection status, and healing stage. Dressings do not heal wounds — they create the optimal environment. Moist wound healing is faster and less painful than dry healing.

Wound conditionDressing typeExamples
Dry / minimal exudateHydrogel → adds moistureIntrasite Gel, Purilon
Low exudateHydrocolloid → maintains moistureGranuflex, DuoDERM
Moderate exudateFoam → absorbs excessAllevyn, Biatain
High exudateAlginate → highly absorbentKaltostat, Sorbsan
Very high exudateAlginate + secondary dressingKaltostat + gauze pad
InfectedAntimicrobial + systemic antibiotics if cellulitisAquacel Ag, Iodosorb, Medihoney
Cavity woundAlginate rope → packs cavityKaltostat rope
Sloughy / necroticHydrogel → autolytic debridementIntrasite Gel
Sutured woundNon-adherent → protects suturesJelonet, Mepitel One

Mechanism: Occlusive dressing with carboxymethylcellulose — forms gel on contact with exudate. Promotes autolytic debridement.

Use for:
  • Low–moderate exudate wounds
  • Pressure ulcers stage 2–3
  • Leg ulcers, minor burns, donor sites
Key points:
  • Stays 3–7 days; waterproof
  • NOT for infected wounds or high exudate
  • Can produce odour (normal)
  • Warm with hands to improve adhesion

Mechanism: Polyurethane foam — high absorbency, breathable. Adhesive and non-adhesive versions available.

Use for:
  • Moderate–high exudate wounds
  • Leg ulcers, pressure ulcers
  • Post-operative and traumatic wounds
Key points:
  • Can stay 3–7 days
  • Non-adherent (won't stick to wound bed)
  • NOT for dry wounds
  • Absorbent side towards wound

Mechanism: Derived from seaweed. Gel-forming, haemostatic. Flat sheets or rope for cavities.

Use for:
  • High exudate wounds
  • Cavity wounds (rope)
  • Bleeding wounds (haemostatic)
  • Pressure ulcers stage 3–4, leg ulcers
Key points:
  • Requires secondary dressing
  • NOT for dry wounds (will adhere)
  • Loosely pack cavities — do not overfill
  • Remove by irrigating with saline

Mechanism: 80–90% water. Donates moisture to dry wounds. Promotes autolytic debridement. Cooling effect reduces pain.

Use for:
  • Dry / sloughy / necrotic wounds
  • Minor burns
  • Painful wounds
Key points:
  • NOT for high exudate (maceration risk)
  • Requires secondary dressing
  • Change daily or when gel dries
TypeExamplesKey notes
SilverActicoat, Aquacel Ag, Allevyn AgBroad-spectrum, sustained release. Grey discolouration temporary.
IodineIodosorb, InadineBroad-spectrum, rapid action. Avoid in thyroid disease and pregnancy.
Honey (medical grade)Medihoney, ActivonAntibacterial, debriding, deodorising. Good for malodorous wounds.
PHMBKendall AMDBroad-spectrum, non-toxic.
Not a Substitute for Systemic Antibiotics

Antimicrobial dressings reduce local bioburden only. They do NOT replace systemic antibiotics when cellulitis or sepsis is present. Review at 2 weeks and stop if infection resolved. Max 2 weeks continuous use.

TypeExamplesNotes
Paraffin gauzeJelonetCheap, easy. Can dry and adhere if little exudate.
Silicone meshMepitel OnePainless removal. Excellent for fragile skin, skin tears, grafts.
Transparent filmTegadermWaterproof, allows inspection. NOT for exuding wounds.
Low-adherent padMelolinAbsorbent pad with non-stick surface. Needs securing with tape.

Indications: Sutured wounds, skin grafts/donor sites, minor burns, abrasions, fragile skin (elderly), secondary intention healing.

Red Flags

Four categories of serious warning signs to recognise and act on immediately. Select each tab to review.

Skin Cancer Warning Signs

Melanoma (Urgent 2-Week Wait Referral)

  • ABCDE positive (Asymmetry, Border irregular, Colour varied, Diameter >6mm, Evolving)
  • 7-point checklist score ≥3
  • Ugly duckling sign (lesion looks different from patient's other moles)
  • New pigmented lesion in patient >50 years
  • Change in size, shape, or colour of existing mole
  • Bleeding, crusting, or itching of pigmented lesion
  • Satellite lesions around pigmented lesion

Squamous Cell Carcinoma (Urgent 2-Week Wait)

  • Non-healing ulcer or nodule >4 weeks
  • Indurated (hard) base
  • Rolled edges
  • Rapid growth
  • Bleeding or crusting
  • Sun-exposed areas (face, ears, scalp, hands)

Basal Cell Carcinoma (Routine Referral — Urgent if Near Eye/Nose/Ear)

  • Pearly, translucent nodule with telangiectasia
  • Central ulceration ("rodent ulcer")
  • Slow-growing but locally invasive
  • Urgent if near eye, nose, or ear (functional risk)

Action: Do NOT excise suspected melanoma or SCC in primary care. Refer urgently (2-week wait) for specialist assessment and excision with appropriate margins.

Infection Warning Signs

Cellulitis / Spreading Infection

  • Spreading erythema beyond wound margins
  • Increasing pain, warmth, swelling
  • Red streaks (lymphangitis)
  • Fever, rigors, malaise
  • Lymphadenopathy

Action: Oral flucloxacillin 500mg QDS for 5–7 days. If systemically unwell, spreading rapidly, or immunocompromised, consider admission for IV antibiotics.

Necrotising Fasciitis (Surgical Emergency)

  • Severe pain out of proportion to clinical signs
  • Rapidly spreading erythema
  • Skin discolouration (purple, black)
  • Bullae, crepitus, anaesthesia of skin
  • Systemic toxicity (fever, tachycardia, hypotension)

Action: Emergency admission. Call ahead. Requires urgent surgical debridement + IV antibiotics. Mortality 20–30% even with treatment.

Septic Arthritis (Post-Joint Injection)

  • Severe joint pain (worse than pre-injection)
  • Hot, swollen, red joint
  • Fever, rigors
  • Unable to move joint
  • Onset usually 24–72 hours post-injection (can be delayed)

Action: Urgent orthopaedic referral same day. Requires joint aspiration (culture, WCC, crystals), IV antibiotics, possible washout. Delay = cartilage destruction.

Vascular Compromise

Arterial Insufficiency (Pre-Procedure — Do Not Proceed)

  • Absent pulses (dorsalis pedis, posterior tibial, radial)
  • Cold, pale limb
  • Prolonged capillary refill (>2 seconds)
  • History of PVD, claudication, rest pain
  • Ulcers with punched-out appearance

Action: Do NOT proceed. Refer to vascular surgery. High risk of non-healing, infection, amputation.

Compartment Syndrome (Post-Procedure — Surgical Emergency)

  • Severe pain out of proportion to clinical signs, not relieved by analgesia
  • Pain on passive stretch of muscles in the compartment
  • Tense, swollen limb
  • Paraesthesia, numbness
  • Pallor, pulselessness (late signs — do not wait for these)

Action: Remove all dressings/bandages immediately. Elevate limb. Emergency referral to orthopaedics. Fasciotomy within 6 hours to prevent permanent damage.

Digital Ischaemia (Post-Ring Block / Tourniquet)

  • White, cold digit
  • Severe pain or numbness
  • Prolonged capillary refill
  • After ring block with adrenaline (contraindicated) or prolonged tourniquet

Action: Remove tourniquet immediately. Warm digit. If adrenaline used, consider phentolamine injection (alpha-blocker reverses vasoconstriction). Urgent referral if not improving within 30 minutes.

Nerve Injury

Immediate Nerve Injury (During Procedure)

  • Patient reports shooting pain or electric shock during injection/incision
  • Immediate numbness or weakness in distribution of nerve
  • Loss of function (e.g., unable to oppose thumb after carpal tunnel injection = median nerve)

Action: Stop procedure immediately. Document carefully. Most are neuropraxia (temporary) — recover in weeks to months. Refer to hand surgery/neurology if no improvement at 3 months or complete loss of function.

Delayed Nerve Injury (Post-Procedure)

  • Progressive numbness or weakness hours to days post-procedure
  • May indicate haematoma compressing nerve
  • Carpal tunnel syndrome worsening after injection

Action: Urgent referral if acute onset with complete loss of function (may need surgical decompression). Routine referral if gradual onset or partial deficit.

High-Risk Anatomical Areas

  • Temporal branch of facial nerve: Forehead procedures (causes brow ptosis)
  • Spinal accessory nerve: Posterior triangle neck (causes shoulder drop)
  • Digital nerves: Finger procedures (run along sides of fingers)
  • Median nerve: Carpal tunnel injections
  • Ulnar nerve: Medial elbow
  • Radial nerve: Lateral elbow

Prevention: Know your anatomy. Use landmarks. If patient reports paraesthesia during injection, withdraw and reposition needle immediately.

Do's & Don'ts

DO

  • Check patient's anticoagulation status before any procedure
  • Obtain informed consent (written for excisions, verbal acceptable for minor procedures)
  • Use aseptic technique for all procedures (sterile gloves, clean skin, no-touch technique)
  • Aspirate before injecting local anaesthetic (avoid intravascular injection)
  • Mark incision lines along Langer's lines (natural skin tension lines)
  • Send all excised tissue for histology (except curettings)
  • Document procedure thoroughly (indication, consent, technique, complications, histology sent)
  • Provide written post-procedure instructions to patient
  • Arrange follow-up for suture removal and histology results
  • Know your limits - refer if uncertain or beyond your competence

DON'T

  • Excise suspected melanoma in primary care (refer urgently for specialist excision)
  • Use adrenaline-containing LA on digits, penis, nose tip, ear lobes (end-arteries)
  • Exceed maximum LA dose (calculate based on patient weight)
  • Inject directly into tendon (risk of rupture)
  • Perform procedures on infected sites (treat infection first, operate later)
  • Use curettage if any doubt about malignancy (destroys tissue architecture)
  • Inject joints more than 3-4 times per year (cartilage damage risk)
  • Apply phenol to wet nail bed (moisture dilutes it - dry thoroughly first)
  • Store phenol and lidocaine together (phenol can contaminate lidocaine)
  • Proceed if patient reports paraesthesia during injection (nerve injury risk)

The Golden Rule of Minor Surgery

"If in doubt, don't cut it out."

When faced with diagnostic uncertainty, always err on the side of caution. It's better to refer a benign lesion than to inadequately excise a malignant one. Your patient's safety and your medicolegal protection depend on knowing when to refer.

Remember: Competence is not just about what you can do, but knowing when NOT to do it.

Minimising the Risk of Litigation in Minor Surgery

Medicolegal considerations and risk reduction strategies for safe minor surgery practice in UK general practice.

Core Medicolegal Principles

  • Competence: Only perform procedures you are trained and competent to do. Maintain skills through regular practice and CPD.
  • Consent: Obtain informed consent. Explain procedure, risks, benefits, alternatives. Document consent clearly.
  • Documentation: Contemporaneous, legible, comprehensive records. "If it's not written down, it didn't happen."
  • Communication: Clear communication with patient before, during, and after procedure. Written post-op instructions.
  • Follow-up: Arrange appropriate follow-up. Chase histology results. Act on abnormal results promptly.
  • Referral: Know when to refer. Don't exceed your competence. Document referrals and ensure patient attends.
  • Indemnity: Ensure adequate medical indemnity insurance covers minor surgery procedures.

Facial Lesions

  • Consider referral to plastic surgery for cosmetically sensitive areas (face, neck, hands)
  • Warn about scarring risk (even with perfect technique, scars are inevitable)
  • Document discussion about scar appearance and patient's acceptance
  • Avoid excising lesions near danger zones (temporal nerve, facial artery) unless confident in anatomy

Keloid Scarring Risk

  • Ask about previous keloid/hypertrophic scars
  • Higher risk in darker skin, chest, shoulders, deltoid region, and earlobes — these are well-known areas to develop keloid scarring
  • Warn patient of risk and document discussion
  • Consider referral if high-risk patient in high-risk area
  • Excision of a hypertrophied scar is best referred to a specialist — do not attempt to revise established keloid or hypertrophied scars in primary care without specialist input

Practice Nurse Consultation

  • If practice nurse performs minor surgery, ensure they are trained, competent, and indemnified
  • GP remains responsible for patient selection, consent, and follow-up
  • Practice Nurses should always seek the opinion of the GP when the wound is not healing satisfactorily — never manage a non-healing post-operative wound in isolation
  • Clear protocols for nurse-led procedures including escalation pathways
  • Regular audit and supervision

Post-Operative Protocols

  • Written post-op instructions (wound care, activity restrictions, when to seek help)
  • Clear plan for suture removal (who, when, where)
  • System to track histology results (don't rely on patient to chase)
  • Action plan for abnormal histology (who contacts patient, how, when)

Documentation

  • Pre-op: indication, consent discussion, risks explained, patient questions answered
  • Intra-op: procedure performed, LA dose and agent used, complications, specimen sent for histology, sutures used
  • Post-op: document the removal of sutures and the state of the wound at time of removal — this is a specific medicolegal requirement
  • Histology tracking system — record when result received, action taken, and that patient informed
  • Use a Minor Surgery Record Book for recording all relevant information: operation performed, local anaesthetic and sutures used, histology results, and the incidence of any complication (e.g. infection). This provides an easily auditable contemporaneous record separate from the main clinical notes.

Patient Information

  • Patients should be supplied with information covering: follow-up arrangements, post-operative care, the complications that may occur, and who to contact if complications arise
  • Provide written information leaflet (procedure, risks, aftercare)
  • Document that leaflet given
  • Allow time for questions
  • Cooling-off period for non-urgent procedures (patient can change mind)

Aseptic Precautions

  • Strict aseptic technique (sterile gloves, clean skin with chlorhexidine/alcohol)
  • No-touch technique (don't touch needle after removing from packet)
  • Single-use vials only (never re-use multi-dose vials between patients)
  • Document aseptic technique used

Avoiding Infected Areas

  • Never inject through infected skin or into infected joint
  • If cellulitis present, treat with antibiotics first, inject later (4-6 weeks)
  • Document that injection site examined and no infection present

Suspected Septic Arthritis

  • If patient presents with hot, swollen, painful joint post-injection, assume septic arthritis until proven otherwise
  • Urgent same-day referral to orthopaedics (don't wait for blood results)
  • Document time of referral, who spoke to, advice given
  • Safety-net: if can't get through to orthopaedics, send to A&E with referral letter

Avoiding Neural/Vascular Damage

  • Know your anatomy (use landmarks, avoid danger zones)
  • If patient reports paraesthesia during injection, STOP immediately, withdraw needle, reposition
  • Document that patient warned about nerve injury risk (rare but possible)
  • If nerve injury occurs, document fully, refer to specialist, apologise (apology is not admission of liability)

Phenol — Storage and Handling

  • Always keep phenol separate from lidocaine AND cleansing agents — phenol can contaminate both, causing chemical burns if a contaminated solution is inadvertently used. Store in completely separate locations.
  • Only open a bottle of phenol when required — do not leave open; reseal immediately after use to prevent contamination and evaporation
  • Always keep phenol in a locked cupboard after use — label clearly with contents, concentration, and date opened
  • Check expiry dates regularly; dispose of expired phenol safely via pharmacy collection

Locked Storage for Phenol

  • Phenol is a controlled drug in some areas (check local policy)
  • Store in locked cupboard (CD cupboard if required locally)
  • Keep register of phenol use (date, patient, amount used)
  • Dispose of expired phenol safely (pharmacy collection)

Silver Nitrate Precautions

  • Use protective jelly (petroleum jelly/Vaseline) to the surrounding skin BEFORE the application of silver nitrate — this is a specific medicolegal requirement to prevent inadvertent chemical burns
  • Ensure that silver nitrate does not touch the surrounding normal skin — apply to the target lesion only; if contact occurs, wipe away immediately with saline-moistened gauze
  • Warn patient about black staining — the stain will fade as the top layer of skin is shed (usually 1–3 weeks)
  • Activate the stick by dipping in water first (the area or the head of the stick must be moist)
  • Don't overuse — excessive or prolonged application causes deeper tissue damage
  • Document: warnings given to patient, site treated, and that protective jelly was applied

Blistering/Scarring Warnings

  • Warn patient that blistering is normal (not a complication)
  • Warn about temporary pigment change (hypopigmentation common, especially darker skin)
  • Warn patient of possible scarring — and record this warning in the patient's medical records. This is a specific medicolegal requirement. Documentation protects the clinician if the patient later claims they were not warned.
  • Document warnings given before obtaining consent

Recording Warnings

  • Document in notes: "Patient warned about blistering, pigment change, and scarring risk. Patient consents to proceed."
  • Consider using a cryotherapy consent form (especially for cosmetic treatments)
  • Provide written aftercare instructions

Avoiding Over-Treatment

  • Follow recommended freeze times: 10–15 seconds (the cryoprobe may cause blistering and scarring if left in contact with the skin for long periods)
  • If repeat treatment is required: repeat at three-weekly intervals — do not re-treat the same lesion at shorter intervals
  • Don't over-treat (longer freeze = higher risk of scarring, not better efficacy)
  • If lesion doesn't respond after 2–3 treatments at appropriate intervals, consider alternative diagnosis or referral

Avoiding Spirit-Based Cleaners

  • Do NOT use alcohol-based skin cleaners immediately before electrocautery (fire risk)
  • If alcohol used, allow to dry completely (at least 2 minutes)
  • Use aqueous chlorhexidine instead (no fire risk)
  • Document skin prep used

Contact with Dressings

  • Do NOT allow hot cautery tip to contact dressings, drapes, or gauze (fire risk)
  • Place cautery in holder when not in use (don't leave on drape)
  • Have water/saline available in case of fire
  • Ensure smoke evacuator or good ventilation (cautery smoke is toxic)

High-Risk Anatomical Sites

The following areas have higher complication rates and should be approached with caution or referred:

  • Face: Cosmetically sensitive. Risk of nerve injury (temporal, facial). Consider plastic surgery referral.
  • Neck: Risk of spinal accessory nerve injury (posterior triangle). Vascular structures. Refer if uncertain.
  • Axilla: Risk of brachial plexus injury. Vascular structures. Difficult haemostasis. Consider referral.
  • Thigh (medial): Risk of femoral vessels/nerve injury. Refer if deep lesion.
  • Popliteal fossa: Risk of popliteal vessels/nerve injury. Refer all lesions in this area.
  • Shin: Poor blood supply. High infection risk. Slow healing. Avoid if possible or use minimal tension closure.

When to Refer

  • Lesion in danger zone and you're not confident in anatomy
  • Lesion >2cm in cosmetically sensitive area
  • Lesion overlying major vessel or nerve
  • Patient has keloid tendency and lesion in high-risk area
  • Suspected malignancy (always refer, never excise in primary care)
  • Patient requests specialist opinion

General Risk Reduction Strategies

  • Training: Attend minor surgery courses. Observe experienced practitioners. Practice on models before patients.
  • Competence: Start with simple procedures. Build experience gradually. Know your limits.
  • Protocols: Develop practice protocols for common procedures. Include consent, technique, follow-up, histology tracking.
  • Audit: Regular audit of outcomes (infection rates, histology results, patient satisfaction, complications).
  • Peer review: Discuss difficult cases with colleagues. Learn from complications (yours and others').
  • Patient selection: Choose appropriate patients. Avoid high-risk patients (PVD, immunosuppressed, bleeding disorders) unless experienced.
  • Equipment: Use appropriate equipment. Maintain and replace regularly. Don't improvise.
  • Indemnity: Ensure adequate medical indemnity insurance. Inform insurer of procedures performed.
  • Apology: If complication occurs, apologise (not admission of liability). Explain what happened. Offer support. Document fully.
  • Reflection: Reflect on every procedure. What went well? What could be improved? Learn continuously.

You've Got This!

Minor surgery is a valuable skill that improves patient care and job satisfaction. Start with simple procedures, build your confidence gradually, and always prioritise patient safety. Remember: competence comes with practice, but wisdom comes from knowing your limits.

Every expert was once a beginner. Keep learning, keep practicing, and don't be afraid to ask for help.

Scroll to Top